Using convalescent plasma from those who have recovered from COVID-19 to treat other patients failed to prevent deaths or worsening illness in one clinical trial, but Canadian researchers continue to study the treatment’s potential.
Using plasma to treat COVID-19 still in question after clinical trial results
